[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100659299":3},{"organization":4,"outcomesModule":7,"designInfo":17,"detailedDescription":11,"studyPopulation":20,"armGroups":11,"interventions":11,"overallOfficials":11,"centralContacts":21,"locations":30,"responsibleParty":105,"collaborators":11,"id":107,"slug":108,"hasResults":109,"nctId":110,"briefTitle":111,"officialTitle":112,"acronym":113,"eligibilityCriteria":114,"healthyVolunteers":109,"sex":115,"minAge":116,"maxAge":11,"enrollmentInfo":117,"targetDuration":11,"studyType":120,"phases":11,"briefSummary":121,"conditions":122,"keywords":124,"overallStatus":33,"whyStopped":11,"lastUpdateSubmitDate":132,"lastUpdatePostDateStruct":133,"startDateStruct":136,"completionDateStruct":138,"leadSponsor":140,"locationsCount":141},{"fullName":5,"class":6},"Universitaire Ziekenhuizen KU Leuven","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":11},[9],{"measure":10,"description":11,"timeFrame":12},"Objective Treatment Response Rate (ORR) per RECIST 1.1.",null,"Baseline to first restaging imaging (~8-12 weeks).",[14],{"measure":15,"description":11,"timeFrame":16},"Progression-Free Survival (PFS)","collected for a maximum of 5 years per patient",{"allocation":11,"interventionModel":11,"interventionModelDescription":11,"primaryPurpose":11,"observationalModel":18,"timePerspective":19,"maskingInfo":11},"COHORT","PROSPECTIVE","Patients with hepatocellular carcinoma (HCC) who received systemic therapy.",[22,27],{"name":23,"role":24,"phone":25,"phoneExt":11,"email":26},"Jeroen Dekervel, MD PhD","CONTACT","+3216344225","jeroen.dekervel@uzleuven.be",{"name":28,"role":24,"phone":25,"phoneExt":11,"email":29},"Sofie De Meulder, MD","Sofie.DeMeulder@azdelta.be",[31,51,66,81,96],{"facility":32,"status":33,"city":34,"state":11,"zip":35,"country":36,"countryCode":37,"cosmosGeoPoint":38,"geoPoint":43,"contacts":44},"Hôpital Universitaire de Bruxelles","RECRUITING","Anderlecht","1070","Belgium","BE",{"type":39,"coordinates":40},"Point",[41,42],4.31454,50.83619,{"lat":42,"lon":41},[45,49],{"name":46,"role":24,"phone":47,"phoneExt":11,"email":48},"Gontran Verset, MD","+32 2 555 55 55","gontran.verset@hubruxelles.be",{"name":46,"role":50,"phone":11,"phoneExt":11,"email":11},"PRINCIPAL_INVESTIGATOR",{"facility":52,"status":33,"city":53,"state":11,"zip":54,"country":36,"countryCode":37,"cosmosGeoPoint":55,"geoPoint":59,"contacts":60},"Imelda Ziekenhuis","Bonheiden","2820",{"type":39,"coordinates":56},[57,58],4.54714,51.02261,{"lat":58,"lon":57},[61,65],{"name":62,"role":24,"phone":63,"phoneExt":11,"email":64},"Pieter-Jan Cuyle, MD","+3215 50 56 91","pieter-jan.cuyle@imelda.be",{"name":62,"role":50,"phone":11,"phoneExt":11,"email":11},{"facility":67,"status":33,"city":68,"state":11,"zip":69,"country":36,"countryCode":37,"cosmosGeoPoint":70,"geoPoint":74,"contacts":75},"AZ Sint-Lucas Brugge","Bruges","8310",{"type":39,"coordinates":71},[72,73],3.22424,51.20892,{"lat":73,"lon":72},[76,80],{"name":77,"role":24,"phone":78,"phoneExt":11,"email":79},"Annelies Holvoet, MD","+3250365155","Annelies.Holvoet@stlucas.be",{"name":77,"role":50,"phone":11,"phoneExt":11,"email":11},{"facility":82,"status":33,"city":83,"state":11,"zip":84,"country":36,"countryCode":37,"cosmosGeoPoint":85,"geoPoint":89,"contacts":90},"Universitair Ziekenhuis Antwerpen","Edegem","2650",{"type":39,"coordinates":86},[87,88],4.44504,51.15662,{"lat":88,"lon":87},[91,95],{"name":92,"role":24,"phone":93,"phoneExt":11,"email":94},"Timon Vandamme, MD PhD","+32 3 821 33 23","Timon.Vandamme@uza.be",{"name":92,"role":50,"phone":11,"phoneExt":11,"email":11},{"facility":97,"status":33,"city":98,"state":11,"zip":99,"country":36,"countryCode":37,"cosmosGeoPoint":100,"geoPoint":104,"contacts":11},"UZ Leuven","Leuven","3000",{"type":39,"coordinates":101},[102,103],4.70093,50.87959,{"lat":103,"lon":102},{"type":106,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR","100659299","strathep-ai-driven-treatment-stratification-for-advanced-hepatocellular-carcinoma-100659299",false,"NCT07863258","STRATHEP: AI-Driven Treatment Stratification for Advanced Hepatocellular Carcinoma","Treatment STRATification in Patients With Advanced HEPatocellular Carcinoma (STRATHEP)","STRATHEP","Participants eligible for inclusion in this Study must meet all of the following criteria:\n\n* Male or female, age \\> 18 years\n* Hepatocellular carcinoma treated with systemic treatment during the disease course\n* Histological confirmation of HCC within one year of the start of systemic treatment OR the availability of an MRI of the liver within 6 months of the start of systemic treatment\n* Left-over tissue from previous diagnostic biopsy available\n* Ability to sign informed consent for secondary use of archival tissue and data collection for study-specific research for patients who are alive and that have not yet reached a 5-year follow-up period.\n\nParticipants eligible for this Study must not meet any of the following criteria:\n\n* Hepatocellular carcinoma not treated systemically\n* Other malignancies of the liver, including cholangiocarcinoma","ALL","18 Years",{"count":118,"type":119},280,"ESTIMATED","OBSERVATIONAL","STRATHEP develops and validates a multimodal AI model to predict treatment response in advanced hepatocellular carcinoma. By integrating digital pathology and MRI radiomics, the project identifies patients likely to benefit from modern systemic therapies, using the RECIST 1.1 framework as the primary benchmark.",[123],"Hepatocellular Carcinoma (HCC)",[125,126,127,128,129,130,131],"Artificial Intelligence","Digital Pathology","Immune Checkpoint Inhibitors","Predictive Biomarkers","Hepatocellular Carcinoma","Machine Learning","Digitalization","2026-10-01",{"date":134,"type":135},"2026-10-07","ACTUAL",{"date":137,"type":119},"2026-10-15",{"date":139,"type":119},"2031-12",{"name":5,"class":6},5]